Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02228681
Title Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Gynecologic Oncology Group
Indications

endometrial carcinoma

Therapies

Tamoxifen

Medroxyprogesterone

Everolimus + Letrozole

Age Groups: adult
Covered Countries USA


No variant requirements are available.